Automata is a Biotech company based in London, UK. It has raised $57M in total funding. Latest round: Series C.
Automata funding overview
Automata is a Biotech company based in London, UK. Automata has raised $57M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in January 2026. The round record for Automata runs through 2026; nothing later has been disclosed. Investors on record include Dimension, Danaher Ventures, Tru Arrow Partners, Octopus Ventures, Entrepreneurs First. 5 distinct backers are named across the disclosed rounds.
Automata at a glance
Total raised
$57M
Latest round
Series C
Latest round date
January 2026
Industry
Biotech
Headquarters
London, UK
Notable investors
Dimension, Danaher Ventures, Tru Arrow Partners, Octopus Ventures, Entrepreneurs First
Frequently asked about Automata funding
How much has Automata raised?
Automata has raised $57M in total disclosed funding across the rounds on record.
Who has invested in Automata?
Dimension, Danaher Ventures, Tru Arrow Partners, Octopus Ventures, Entrepreneurs First are named among the investors backing Automata.
What was the latest Automata funding round?
The most recent disclosed round is a Series C, announced in January 2026.
Where is Automata based?
Automata is based in London, UK.
What sector does Automata operate in?
Automata is tracked under Biotech from London, UK, with $57M in disclosed funding.
When did Automata last raise?
The last disclosed Automata round closed in January 2026 at Series C.
Every Automata figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in London at a similar stage.
